20272 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing heavy metals Platinum compounds
TREATMENT OF ONCOGENE-DRIVEN CANCERS
#302DELAYED AND SUSTAINED DELIVERY OF ANTICANCER DRUGS
#303METHODS FOR MODULATING A TREATMENT REGIMEN
#304CO-CRYSTAL COMPOSITION AND ITS PHARMACEUTICAL USE
#305ADC FOR A TREATMENT CONCOMITANT WITH OR SUBSEQUENT TO DOCETAXEL
#306Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers
#307Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers
#308COMBINATION OF MONALIZUMAB, DURVALUMAB, CHEMOTHERAPY AND BEVACIZUMAB OR CETUXIMAB FOR THE TREATMENT OF COLORECTAL CANCER
#309METHODS OF TREATING GASTROINTESTINAL CANCERS AND TUMORS THEREOF USING COMBINATION THERAPY
#310METHODS FOR PREVENTING TOXICITY OF PLATINUM DRUGS
#311COMPOSITIONS AND METHODS TO TREAT CANCER
#312PH responsive drug conjugated nanocarriers
#313CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION
#314ANTIBODY FOR ANTI-CLAUDIN 18A2 AND USE THEREOF
#315BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER AND ANGIOGENESIS
#316METHODS AND USES OF VARIANT CD80 FUSION PROTEINS AND RELATED CONSTRUCTS
#317IMMUNE MODULATORY COMPOSITIONS AND METHODS FOR TREATING CANCERS
#318CARBOPLATIN COMPLEX AND PHARMACEUTICAL PREPARATION THEREOF
#319AMPHIPHILIC PLATINUM (IV) PRODRUG AND CANCER TREATMENT PROCESS
#320COMPOUNDS AND METHODS FOR MANAGING CANCER THROUGH IMMUNE SYSTEM
#321Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
#322Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
#323COMBINATION THERAPIES FOR USE IN TREATING CANCER
#324METHODS FOR IMPROVING THE EFFICACY OF A SURVIVIN THERAPEUTIC IN THE TREATMENT OF TUMORS
#325Strategies to enhance lung cancer treatment
#326ADHESIVE/ADSORPTION SWITCH ON NANOPARTICLES TO INCREASE TUMOR UPTAKE AND DELAY TUMOR CLEARANCE
#327KRAS ANTAGONISTS
#328PREPARING LIPOSOMES WITH HIGH DRUG LOADING CAPACITY AND THE USE THEREOF
#329BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA
#330ANALOGUES OF OLEUROPEIN AND OLEACEIN AND USES THEREOF
#331ANTI-TUMOR PLATINUM-BASED DRUG MINERALIZED PROTEIN NANOPARTICLE, PREPARATION METHOD THEREFOR AND USE THEREOF
#332Anti-matrix metalloproteinase 7 (MMP-7) inhibitory antibody and uses thereof
#333Methods for treating brain metastasis
#334Antidotes to Cyanide Poisoning
#335MACROCYCLIC PEPTIDES FOR TARGETED INHIBITION OF AUTOPHAGY
#336COMPOSITIONS AND METHODS FOR CANCER THERAPY
#337Pharmaceutical compounds and therapeutic methods
#338Human papilloma virus as predictor of cancer prognosis
#339SUBCONJUNCTIVAL CHEMOTHERAPEUTIC DELIVERY BY FIBRIN SEALANT IN THE TREATMENT OF RETINOBLASTOMA
#340GLUCOCORTICOID RECEPTOR MODULATORS
#341Solid forms of a CD73 inhibitor and the use thereof
#342Crystalline forms of a quinazoline compound and its hydrochloride salts
#343Drug delivery system
#344Micro- or nano emulsions including anticancer drugs
#345Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer
#346METHODS OF TREATING CANCER WITH AN ANTI-PD-L1 ANTIBODY
#347KITS AND METHODS FOR TREATING CANCERS
#348METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS
#349OX40 ANTIBODY, PREPARATION METHOD THEREOF AND USE THEREOF
#350Combination Therapy for Cancer
#351METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY
#352Inhibitors of ARG1 and/or ARG2
#353Glutaminase inhibitor therapy
#354NUCLEOPHILIC CHEMICALS USEFUL IN THE TREATMENT OF CISPLATIN-INDUCED SENSORY NEUROPATHY AND OTOTOXICITY
#355METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS
#356TREATMENT OF CANCER BY COMBINATION OF IMMUNE CHECKPOINT INHIBITOR AND FOLFIRINOX THERAPY
#357METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES
#358Guanylurea functionalized peptides and proteins for therapeutics
#359Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein
#360COMBINATION THERAPY FOR TREATMENT OF DISEASE
#361[6R]-MTHF - an efficient folate alternative in 5-fluorouracil based chemotherapy
#362Methods of treating pancreatic cancer
#363Nucleic acid nanocarrier drug and preparation method thereof
#364EZH1/2 DUAL INHIBITOR-CONTAINING PHARMACEUTICAL COMPOSITION TO BE USED AS A COMBINATION DRUG
#365BRUSH PRODRUGS AND USES THEREOF
#366Vaccine adjuvants and formulations
#367METHODS FOR ENHANCING CANCER IMMUNOTHERAPY
#368MALONATE SALT OF VARLITINIB
#369NANOPARTICLE FORMULATIONS AND METHODS OF USE FOR ALPHA CONNEXIN C-TERMINAL PEPTIDES
#370METHODS OF TREATING CANCERS HAVING A DEREGULATED NRF2/KEAP1 PATHWAY
#371TREATMENT OF T CELL LYMPHOMA
#372Heterocyclic compounds, preparation methods and uses thereof
#373MICROCARRIER FOR EMBOLIZATION AND PREPARATION METHOD THEREFOR
#374Methods of Treating Cancer
#375ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF
#376CD73 inhibitors
#377BCL-2 inhibitors
#378TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT
#379NOVEL STRAINS HAVING EFFECTS OF PREVENTING OR TREATING CANCERS
#380COMPOSITIONS AND METHODS FOR TREATING CANCER
#381CONTROLLED DRUG RELEASE FORMULATION
#382BCL-2 inhibitors
#383COMPOUNDS AND METHODS FOR CSK MODULATION AND INDICATIONS THEREFOR
#384Priming of cancer cells with low dose naltrexone
#385LIQUID EMBOLICS
#386Oral drug delivery composition containing oxaliplatin and method for preparing same
#387Platinum(II) ammine selenourea complexes and methods of treating cancer
#388Fine nano-sized medicinal agent and use thereof
#389METHODS OF USING REBASTINIB IN THE TREATMENT OF DISORDERS
#390Platinum-based amphiphile prodrugs
#391Methods and apparatuses for treating tumors
#3925-ACETAMIDOMETHYL-OXAZOLIDINONE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER
#393NANOPARTICLE FORMULATIONS OF IKE AND METHODS OF USE THEREOF
#394EFFECTS OF A SHORT-TERM FASTING MIMICKING DIET ON QUALITY OF LIFE AND TOLERANCE TO CHEMOTHERAPY IN PATIENTS WITH CANCER
#395PREDICTIVE 7-GENE ASSAY AND PROGNOSTIC PROTEIN BIOMARKER FOR NON-SMALL CELL LUNG CANCER
#396Phosphate of platinum compound and preparation method therefor
#397Compositions and methods for enhancing cancer chemotherapy
#398Platinum-resistant cancer treatment
#399Systems and methods for treating cancer
#400NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS
#401Near-IR activatable fluorescent small molecules with dual modes of cytotoxicity
#402COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#403Compositions comprising urolithin a and uses thereof in treating kidney injury
#404Pharmaceutical composition for prevention or treatment of flavivirus infection
#405PYRVINIUM PAMOATE THERAPIES AND METHODS OF USE
#406USE OF AMISULPRIDE AS AN ANTI-EMETIC
#407TAXANE-LIPID-POLYSACCHARIDE DUAL CONJUGATES, PREPARATION METHODS THEREOF AND USES THEREOF
#408A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER
#409Urinary DNA Detection For Urothelial Cancer
#410CCR5 BINDING AGENT FOR THE TREATMENT OF CCR5 POSITIVE METASTATIC CANCER
#411Treatment for reducing adverse events including chemotherapy discomfort and other conditions
#412Combined pharmaceutical formulation comprising drug-containing liposome composition and platinum preparation
#413GAMMA POLYGLUTAMATED AMINOPTERIN AND USES THEREOF
#414Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the same
#415TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS
#416Heterocyclic compounds, preparation and methods and uses thereof
#417COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR
#418METHOD FOR TREATMENT OF CHOLANGIOCARCINOMA WITH COLD ATMOSPHERIC PLASMA AND FOLFIRINOX
#419METHODS OF CANCER TREATMENT USING AN ATR INHIBITOR
#420SYNERGISTIC PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
#421METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES
#422COMBINATION OF LIF INHIBITORS AND PLATINUM-BASED ANTINEOPLASTIC AGENTS FOR USE IN TREATING CANCER
#423MDM2 inhibitor and a platinum compound for cancer treatment
#424Alpha polyglutamated methotrexate and uses thereof
#425Gamma polyglutamated pemetrexed and uses thereof
#426Pyridone A2R antagonists
#427COMBINATION THERAPIES FOR TREATING CANCER
#428Gamma polyglutamated methotrexate and uses thereof
#429Pharmaceutical combination for the treatment of cancer
#430STROMA-TARGETING TREATMENT FOR PATIENTS WITH ELEVATED ADAM12 LEVELS
#431METHODS FOR ADOPTIVE CELL THERAPY TARGETING ROR1
#432Strains having effects of preventing or treating cancers
#433MODIFIED PLATINUM COMPOUNDS AND THERAPEUTIC USES THEREOF
#434Guanylurea functionalized peptides and proteins for therapeutics
#435Substituted pyrimidines as CDK4/6 inhibitors
#436Procaspase 3 activation by combination therapy
#437Substituted fused heteroaromatic tricyclic compounds as kinase inhibitors and the use thereof
#438DRUG DELIVERY SYSTEMS
#439EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE
#440Phosphaplatin compounds as immuno-modulatory agents and therapeutic uses thereof
#441Gene Therapy For Mesothelioma
#442SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR TREATING CANCER
#443SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR TREATING CANCER
#444METHODS FOR IMPROVING ADOPTIVE CELL THERAPY
#445COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO
#446Combination therapy for treating cancer
#447Pharmaceutical co-crystal composition and use thereof
#448Apparatus And Method For Forming Melt-Formed Inorganic Fibres
#449METHOD OF TREATING CANCER
#450Peptides Having Anti-Inflammatory Properties
#451CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS
#452Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
#453Treatment of ovarian cancer in patients with ascites using a specific binding agent of human angiopoietin-2 in combination with a taxane
#454Nucleic acid simultaneously inhibiting expression of mTOR gene and STAT3 gene
#455Anti-PD-L1 antibodies and uses thereof
#456ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF OVARIAN CANCER
#457COMBINATORIAL THERAPIES FOR THE TREATMENT OF NEOPLASIAS USING THE OPIOID GROWTH FACTOR RECEPTOR
#458Use of APE1/Ref-1 inhibitors for treatment of retinal diseases
#459Bilirubin derivative-based diagnostic and therapeutic ultrasound contrast agent
#460CANCER TREATMENTS
#461Gamma polyglutamated raltitrexed and uses thereof
#462TREATMENT WITH ANTI-VEGF ANTIBODIES
#463MicroRNA-based methods and assays for osteocarcinoma
#464IMPROVING ANTI-PD-1 CANCER THERAPY
#465Anti-annexin A2 monoclonal antibodies
#4663,5-diarylidenyl-n-substituted-piperid-4-one-derived inhibitors of Stat3 pathway activity and uses thereof
#467Administration of aurora kinase inhibitor and chemotherapeutic agents
#468Biodegradable Polymer and Use Thereof
#469METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES
#470Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer
#471Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer
#472Composition comprising an algal proteoglycan extract and use thereof
#473IBRUTINIB COMBINATION THERAPY
#474Glutaminase inhibitor therapy
#475PARTICLES
#476Kits comprising myokines and platinum-based chemotherapeutic agents for treating colorectal cancer
#477Composition comprising an algal proteoglycan extract and use thereof
#478Alpha polyglutamated pemetrexed and uses thereof
#479PLATINUM-RESISTANT CANCER TREATMENT
#480Composition comprising an algal proteoglycan extract and use thereof
#481Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio
#482Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibition
#483Combined preparations for the treatment of cancer
#484Phosphaplatin liquid formulations
#485COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY
#486MicroRNA-based methods and assays for osteocarcinoma
#487Targeted Therapeutic Nanoparticles And Methods Of Making And Using Same
#488miR-133a as a marker for colorectal cancer
#489Human papilloma virus as predictor of cancer prognosis
#490Chlorin-vitamin conjugates
#491Antidotes to cyanide poisoning
#492MAFG AS A POTENTIAL THERAPEUTIC TARGET TO RESTORE CHEMOSENSITIVITY IN PLATINUM-RESISTANT CANCER CELLS
#493Treating Gastric Cancer Using TTFields Combined with XELOX, FOLFOX or the Individual Constituents Thereof
#494Plectin-1 binding antibodies and uses thereof
#495Cancer treatments
#496COMBINATION THERAPY FOR CANCER
#497ASSESSING AND TREATING MAMMALS HAVING POLYPS
#498Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
#499Compositions and methods for parenteral administration of therapeutic agents
#500Prevention and reversal of inflammation induced DNA damage
#501Drug combination with antitumor effects
#502COMBINATION THERAPY COMPRISING NANOPARTICLES OF A TAXANE AND ALBUMIN WITH ABT-263 IN METHODS FOR TREATING CANCER
#503Anti-OX40 antibodies and uses thereof
#504Methods of inhibiting cell proliferation and METTL8 activity
#505Nucleic acid, chimeric antigen receptor expression plasmid, chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer
#506Oligonucleotide analogues incorporating 5-aza-cytosine therein
#507Gold(I) And Platinum(II) With Isocyanide Ligand Complexes: Synthesis And Biological Activity
#508NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS
#509METHOD OF INDIRECT IMMUNIZATION OF HUMAN OVARIAN CANCER PATIENTS THROUGH SELECTION OF XENOGENEIC IMMUNOGLOBULIN FC PORTIONS
#510METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY
#511Anticancer trail-targeted plant virus particles
#512Methods of treating pancreatic cancer
#513TREATMENT WITH ANTI-VEGF ANTIBODIES
#514Treatment of cancer with specific RXR agonists
#515Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer
#516NANOSTRUCTURED AND BIOCOMPATIBLE BIOCATALYSTS FOR USE IN CANCER TREATMENT
#517Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
#518METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES
#519SSTR-TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF
#520Drug delivery devices and methods for treatment of bladder cancer with oxaliplatin
#521Methods for reducing side effects of immunotherapy
#522Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant
#523METHOD OF INDIRECT IMMUNIZATION OF HUMAN OVARIAN CANCER PATIENTS THROUGH SELECTION OF XENOGENEIC IMMUNOGLOBULIN FC PORTIONS
#524USE OF AMISULPRIDE AS AN ANTI-EMETIC
#525Method For Treating Cancer
#526Methods for treating brain metastasis
#527Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapy
#528Combination Therapy for Treating Proliferative Diseases
#529Embolic material and method for producing same
#530Endoglin Antibodies
#531Antibodies and methods for making and using the same
#532COMBINATION THERAPY FOR CANCER USING ANTI-GITR ANTIBODIES
#533Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
#534Treatment cancers using a combination comprising PARP inhibitors
#535MICROSPHERES CONTAINING THERAPEUTIC AGENTS AND RELATED METHODS OF USE
#536Oncolytic virus growth method and antitumor agent
#537Apparatus for treating pathological cells
#538Combination therapy comprising Varlitinib and an anticancer agent
#539COMBINATION BETWEEN TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, AN ANTITUMOR PLATINIUM COMPLEX, AND AN IMMUNE CHECKPOINT MODULATOR
#540Applications of pair-production for improved radiotherapy
#541ADMINISTRATION OF A THIOL-BASED CHEMOPROTECTANT COMPOUND
#542Systems and methods for treating cancer
#543Two-stage microparticle-based therapeutic delivery system and method
#544Method for treating cancer using chemokine antagonists
#545Exosomal compositions and methods for the treatment of disease
#546Method of treatment for pancreatic cancer by administering a human-mouse cross-reactive ADAM 17 antibody
#547PHARMACEUTICAL CO-CRYSTAL COMPOSITION AND USE THEREOF
#548Methods of treating pancreatic cancer
#549Nucleic acid simultaneously inhibiting expression of mTOR gene and STAT3 gene
#550Therapeutic Combination for the Treatment of Cancer
#551Medical use of sPLA2 hydrolysable liposomes
#552EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#553Anti-ICOS antibodies
#554Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same
#5554-amino-2-pyrido-bicyclic pyrimidines and use thereof as topoisomerase II inhibitors
#556TREATMENT WITH ANTI-VEGF ANTIBODIES
#557Methods of cancer treatment
#558PT(IV) PRODRUGS
#559Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
#560Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers
#561Glutaminase inhibitor therapy
#562Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of bladder cancer
#563SIMVASTATIN AND CHEMOTHERAPEUTIC CONJUGATES WITH A HEPTAMETHINE CARBOCYANINE DYE RESENSITIZE HUMAN TUMORS TO HORMONAL ANTAGONISTS AND CHEMOTHERAPY
#564Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitors
#565OPRT expression and cancer treatment outcome
#566Compounds and methods to sensitize cancer cells to cisplatin
#567Polyoxometalate complexes and uses in managing cancer
#568Nanocomplex
#569Pharmaceutical solution having a toxicity-reducing effect for antitumor drugs, and pharmaceutical composition comprising same
#570Apparatus and method for the treatment of melanoma
#571POLYPEPTIDES FOR IMPROVED RESPONSE TO ANTI-CANCER THERAPY
#572Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibition
#573Antibody for anti-claudin 18A2 and use thereof
#574Hierarchical siliceous mesosilicalite nanocarrier loaded with platinum(II) complex
#575BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER AND ANGIOGENESIS
#576Anti-IGF antibodies
#577Amino acid- and peptide-steroid conjugates and use thereof
#578Chlorin-vitamin conjugates
#579POTENTIATING THE EFFECT OF ATP RELEASE
#580COMPOSITIONS FOR RADIOTHERAPY AND USES THEREOF
#581Predicting optimal chemotherapy for CRC
#582Veliparib in Combination With Carboplatin for the Treatment of Triple Negative Breast Cancer
#583Pharmaceutical composition containing a cis-diamine platinum thione complex
#584Combination therapies using HDAC inhibitors
#585Pyrvinium pamoate therapies and methods of use
#586IMMUNE MEMORY INDUCTION BY PLATINUM BASED COMPOUNDS
#587Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof
#588Microvascular blood flow decreasing agent and use thereof
#589Gelling compositions for treating malignant tumours and/or preventing tumour recurrence
#590USE OF DIANHYDROGALACTITOL OR DERIVATIVES OR ANALOGS THEREOF FOR TREATMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM MALIGNANCIES
#591Anti-annexin A2 monoclonal antibodies
#592Compositions for the treatment of neuropathic pain and sensitization of tumors to chemotherapies
#593MEBENDAZOLE CANCER THERAPIES AND METHODS OF USE
#594Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignancies
#595Method for treating a prolifitive disorder with a cis-diamine platinum complex
#596COMBINATIONAL LIPOSOME COMPOSITIONS FOR CANCER THERAPY
#597NOVEL CLASS OF QUINOLONE HETEROCYCLIC AROMATIC MOLECULES FOR CANCER TREATMENT
#598Methods of treating pancreatic cancer
#599Synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
#600COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES